Mediwound Financial Statements From 2010 to 2026

Mediwound Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 12 M 11.5 M 5.1 M Slightly volatile Total Assets 47.4 M 84.5 M 43.7 M Slightly volatile Short and Long Term Debt Total 4.1 M 8 M 5.1 M Pretty Stable Other Current Liabilities 26.6 M 25.3 M 6.8 M Slightly volatile Total Current Liabilities 32 M 30.5 M 10.5 M Slightly volatile Other Liabilities 15.9 M 23.6 M 19 M Slightly volatile Property Plant And Equipment Net 25.1 M 23.9 M 6.7 M Slightly volatile Accounts Payable 3.2 M 4.7 M 2.8 M Slightly volatile Cash 14.6 M 8.2 M 15.4 M Pretty Stable Non Current Assets Total 25.8 M 24.5 M 11.1 M Pretty Stable Other Assets 311.2 K 327.6 K 3 M Slightly volatile Cash And Short Term Investments 33.1 M 49.6 M 27.9 M Slightly volatile Net Receivables 4.4 M 6.7 M 3.9 M Slightly volatile Common Stock Total Equity 61 K 86.2 K 56.7 K Slightly volatile Liabilities And Stockholders Equity 47.4 M 84.5 M 43.7 M Slightly volatile Non Current Liabilities Total 16.3 M 14.2 M 18.1 M Very volatile Inventory 1.8 M 3.1 M 1.6 M Slightly volatile Other Current Assets 533.4 K 412.2 K 594.9 K Very volatile Other Stockholder Equity 147.1 M 271.4 M 132.5 M Slightly volatile Total Liabilities 32.2 M 48.7 M 28.3 M Slightly volatile Property Plant And Equipment Gross 34.7 M 33 M 8.7 M Slightly volatile Total Current Assets 39.5 M 60 M 33.7 M Slightly volatile Short Term Debt 357.4 K 376.2 K 2.2 M Slightly volatile Intangible Assets 84.6 K 89.1 K 1.3 M Slightly volatile Common Stock 259.6 K 247.2 K 96.5 K Slightly volatile Property Plant Equipment 2.6 M 4.1 M 2.5 M Slightly volatile Long Term Debt 7.8 M 8.5 M 7.3 M Slightly volatile Deferred Long Term Liabilities 811.4 K 889.2 K 986.2 K Slightly volatile Short and Long Term Debt 2.2 M 2 M 2.4 M Slightly volatile Current Deferred Revenue 10.3 K 10.8 K 139.5 K Very volatile Non Current Liabilities Other 10.8 M 7.3 M 15.7 M Slightly volatile Capital Surpluse 153.8 M 162 M 141.9 M Slightly volatile Net Working Capital 21 M 23.1 M 29.8 M Slightly volatile Capital Stock 132.3 K 247.2 K 107.2 K Slightly volatile Long Term Debt Total 1.6 M 1.8 M 2 M Slightly volatile Capital Lease Obligations 7.9 M 7.5 M 3.1 M Slightly volatile
Mediwound Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 869.2 K 1.7 M 813.7 K Slightly volatile Interest Expense 436.1 K 504.9 K 539.1 K Slightly volatile Selling General Administrative 11.7 M 11.2 M 5.6 M Slightly volatile Other Operating Expenses 24.3 M 45.5 M 22.6 M Slightly volatile Research Development 6.5 M 9.5 M 6 M Slightly volatile Total Operating Expenses 16.2 M 24.3 M 14.8 M Slightly volatile Cost Of Revenue 22.3 M 21.2 M 8.7 M Slightly volatile Selling And Marketing Expenses 3.6 M 2.9 M 3.9 M Pretty Stable Interest Income 2.5 M 2.4 M 1.1 M Slightly volatile Reconciled Depreciation 1.2 M 1.7 M 910.4 K Slightly volatile
Mediwound Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 2 M 3.6 M 1.9 M Slightly volatile Begin Period Cash Flow 18.4 M 13.6 M 15.9 M Slightly volatile Depreciation 869.2 K 1.7 M 813.7 K Slightly volatile Capital Expenditures 7.6 M 7.2 M 2.1 M Slightly volatile End Period Cash Flow 19 M 10.5 M 16.1 M Pretty Stable Sale Purchase Of Stock 17.7 M 20.4 M 20.9 M Very volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 9.58 10.08 179 Slightly volatile Days Sales Outstanding 115 121 1.1 K Slightly volatile Stock Based Compensation To Revenue 0.17 0.18 5.9549 Slightly volatile Capex To Depreciation 4.0 3.81 2.1334 Pretty Stable EV To Sales 9.46 9.96 144 Slightly volatile Inventory Turnover 3.98 6.17 4.2669 Slightly volatile Days Of Inventory On Hand 58.21 61.27 315 Slightly volatile Payables Turnover 4.25 4.05 2.3075 Slightly volatile Research And Ddevelopement To Revenue 0.45 0.47 7.3008 Slightly volatile Capex To Revenue 0.4 0.36 0.6402 Slightly volatile Cash Per Share 8.39 4.98 6.6351 Very volatile Days Payables Outstanding 88.57 93.23 410 Slightly volatile Intangibles To Total Assets 0.0015 0.0015 0.0469 Slightly volatile Current Ratio 2.15 2.26 4.6738 Pretty Stable Receivables Turnover 2.76 3.11 2.6104 Slightly volatile Capex Per Share 0.6 0.57 0.2941 Slightly volatile Revenue Per Share 2.3 1.83 2.1302 Slightly volatile Interest Debt Per Share 0.38 0.68 0.512 Pretty Stable Debt To Assets 0.0507 0.0849 0.0587 Slightly volatile Graham Number 17.57 12.18 12.9916 Slightly volatile Operating Cycle 174 183 907 Slightly volatile Days Of Payables Outstanding 88.57 93.23 410 Slightly volatile Quick Ratio 2.04 2.14 4.4679 Pretty Stable Net Income Per E B T 1.3 1.15 1.2017 Pretty Stable Cash Ratio 0.38 0.4 2.3949 Pretty Stable Days Of Inventory Outstanding 58.21 61.27 315 Slightly volatile Days Of Sales Outstanding 115 121 1.1 K Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.9 1.31 1.1366 Pretty Stable Fixed Asset Turnover 0.83 0.88 2.0565 Slightly volatile Debt Ratio 0.0507 0.0849 0.0587 Slightly volatile Price Sales Ratio 9.58 10.08 179 Slightly volatile Asset Turnover 0.29 0.25 0.267 Slightly volatile
Mediwound Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 80.1 M 90.1 M 98.3 M Slightly volatile Enterprise Value 57 M 64.1 M 70 M Slightly volatile

Mediwound Fundamental Market Drivers

Mediwound Upcoming Events

About Mediwound Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:

How To Invest In Mediwound Details

Is Mediwound Stock a good investment? Details

What is Mediwound's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details